1/24
Vocabulary-style flashcards covering key pharmacology concepts from the notes.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Topical drug absorption in infants
Infants have thinner skin and greater blood flow, causing faster absorption and higher risk of toxicity from topical meds; avoid combining routes in this age group.
Creatinine clearance
Best measure of renal function in older adults; reflects glomerular filtration rate; serum creatinine alone can be misleading due to reduced muscle mass.
Morphine and naloxone receptor action
Both act directly at opioid receptors; neither alters transmitter reuptake, release, or storage.
Beta-1 agonist
Increases heart rate and blood pressure; used in heart failure; not indicated for kidney, respiratory, or liver failure.
Pilocarpine
Muscarinic agonist used mainly to reduce intraocular pressure in glaucoma; not for excessive secretions; does not inhibit bladder function.
Physostigmine
Acetylcholinesterase inhibitor used to treat muscarinic antagonist toxicity; atropine worsens drying effects and is not the antidote.
Myasthenia gravis – swallowing safety
Assess swallowing ability; parenteral forms may be needed if swallowing is impaired; monitor eyelid elevation, fatigue, and skeletal muscle strength.
Pancuronium
Competitive neuromuscular blocker; first muscles affected are eyelids; patient remains conscious and awake; talk to patient during care.
Atracurium histamine release
Can cause hypotension due to histamine release; unlike pancuronium, which does not primarily cause this effect.
Neuromuscular blocking agents
Produce muscle paralysis without analgesia; used for ECT, intubation, and surgery; not indicated for treating malignant hyperthermia.
Catecholamines – duration and administration
Brief duration due to MAO/COMT; often require continuous infusion; cannot be given orally; do not cross the blood–brain barrier.
Noncatecholamines and the blood-brain barrier
Noncatecholamines cross the blood–brain barrier and are not degraded by MAO in the same way as catecholamines.
Dopamine adverse effects
Common adverse effects include angina, dysrhythmias, and tachycardia; diuretics may increase urine output when used with dopamine.
Alpha-adrenergic antagonists effects
Block alpha-1 receptors causing venous/arterial dilation; can improve cardiac output and cause adverse effects like reflex tachycardia, nasal congestion, orthostatic hypotension, and inhibited ejaculation.
Reflex tachycardia (alpha blockade)
A common adverse effect of alpha-adrenergic blockade due to sudden BP changes.
Clonidine – xerostomia management
Xerostomia is common; advise chewing sugar-free gum or sipping water; CNS effects and potential sedation; avoid abrupt discontinuation due to rebound hypertension.
Methyldopa Coombs test
Positive Coombs’ test occurs in 10–20% of chronic methyldopa use and can signal immune-mediated hemolytic anemia; monitor liver function and hematologic status.
Clonidine vs. pregnancy safety
Clonidine is contraindicated during pregnancy; methyldopa is often used historically in pregnancy for hypertension.
Pediatric pharmacology differences
Drugs can affect children differently than adults; many pediatric drugs are under-tested; infants metabolize more slowly and side effects can differ, requiring careful dosing.
Cluster medication administration
Group medications to reduce the number of dosing times per day, minimizing confusion and nonadherence.
Local anesthetics and axonal conduction
Drugs that alter axonal conduction are generally nonselective; many PNS drugs affect synaptic transmission rather than axonal conduction.
Autonomic control of digestion
Digestion is regulated by the parasympathetic nervous system; the sympathetic system does not regulate digestive functions.
Bethanechol contraindication in asthma
Bethanechol is contraindicated in active or latent asthma due to muscarinic receptor–mediated bronchoconstriction.
Organophosphate poisoning management (airway first)
Initial priority is maintaining airway and preventing death from apnea; pralidoxime is the antidote; atropine controls secretions; diazepam may treat seizures.
Pralidoxime (2-PAM)
Specific antidote for organophosphate/muscarinic receptor poisoning; reactivates acetylcholinesterase; use after airway is secured.